For grapefruit juice interaction, which creatinine clearance category is relevant?

For grapefruit juice interaction, which creatinine clearance category is relevant?

• A. CrCl 60-90
• B. CrCl 50-79 mL/min
• C. CrCl 20-40
• D. CrCl >80

Answer: (B)

Grapefruit juice inhibits intestinal CYP3A4, which raises the oral bioavailability and plasma levels of many CYP3A4–substrate drugs. When renal function is impaired, the overall clearance of many medications is already reduced, so any additional increase in exposure from the grapefruit interaction becomes more clinically meaningful. The mild-to-moderate impairment range, about 50–79 mL/min, is where this interaction is most likely to be impactful in practice: the patient isn’t fully normal, but isn’t severely compromised either, so the combined effect of reduced clearance and grapefruit-mediated higher drug levels warrants attention, possible dose adjustment, or monitoring. In patients with normal renal function (>80), the interaction may be less clinically significant, and in severe impairment (20–40), clearance is already substantially reduced, amplifying risk but often requiring broader management considerations beyond the grapefruit interaction alone. Hence, the most relevant category is CrCl 50–79 mL/min.

Grapefruit juice inhibits intestinal CYP3A4, which raises the oral bioavailability and plasma levels of many CYP3A4–substrate drugs. When renal function is impaired, the overall clearance of many medications is already reduced, so any additional increase in exposure from the grapefruit interaction becomes more clinically meaningful. The mild-to-moderate impairment range, about 50–79 mL/min, is where this interaction is most likely to be impactful in practice: the patient isn’t fully normal, but isn’t severely compromised either, so the combined effect of reduced clearance and grapefruit-mediated higher drug levels warrants attention, possible dose adjustment, or monitoring. In patients with normal renal function (>80), the interaction may be less clinically significant, and in severe impairment (20–40), clearance is already substantially reduced, amplifying risk but often requiring broader management considerations beyond the grapefruit interaction alone. Hence, the most relevant category is CrCl 50–79 mL/min.